Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 155, Issue -, Pages 113710
Publisher
Elsevier BV
Online
2022-09-23
DOI
10.1016/j.biopha.2022.113710
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
- (2020) J. Turnidge et al. CLINICAL MICROBIOLOGY AND INFECTION
- Concerns About the Association Between Poor Clinical Outcomes and the Minimum Inhibitory Concentrations Determined by Etest
- (2019) Aristine Cheng et al. CLINICAL INFECTIOUS DISEASES
- Pharmacodynamics of daptomycin when prescribed in combination with other antibiotics for treatment of enterococcal bacteremia
- (2019) Lindsay M. Avery et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis
- (2019) Changcheng Shi et al. Journal of Global Antimicrobial Resistance
- Efficacy of Daptomycin Monotherapy and In Combination with β-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect
- (2018) Razieh Kebriaei et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests
- (2018) Shelley A. Campeau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model
- (2018) James M. Kidd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Statin Coadministration on the Risk of Daptomycin-Associated Myopathy
- (2018) Ryan K Dare et al. CLINICAL INFECTIOUS DISEASES
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
- (2018) Yu-Chung Chuang et al. Scientific Reports
- Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
- (2018) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- Bacterial Resistance in the Intensive Care Unit of developing countries: report from a tertiary hospital in Kazakhstan
- (2018) Dmitriy Viderman et al. Journal of Global Antimicrobial Resistance
- Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans
- (2017) Johannes J. M. van Delden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Influence of Minimum Inhibitory Concentration in Clinical Outcomes ofEnterococcus faeciumBacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
- (2016) Bhavarth S. Shukla et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose
- (2016) Y.-C. Chuang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
- (2015) Pamela A. Moise et al. CLINICAL THERAPEUTICS
- Interethnic Differences in Pharmacokinetics of Antibacterials
- (2014) Danny Tsai et al. CLINICAL PHARMACOKINETICS
- Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
- (2014) A. Hall Snyder et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Correlation between Mutations inliaFSRof Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
- (2012) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
- (2011) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of multidrug-resistant enterococcal infections
- (2011) C.A. Arias et al. CLINICAL MICROBIOLOGY AND INFECTION
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
- Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic options for infections due to vancomycin-resistant enterococci
- (2009) Jiun-Ling Wang et al. EXPERT OPINION ON PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now